Compare StandardAero Inc. Common Stock (SARO) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
StandardAero Inc. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? StandardAero Inc. Common Stock trades at $19.73 (market cap $6.58B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: StandardAero Inc. Common Stock is far larger — about 3.7× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, StandardAero Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold StandardAero Inc. Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| SARO | VIR | |
|---|---|---|
Market Cap | $6.58B | $1.80B |
Volume | 3,663,186 | 1,782,836 |
Sector | Industrials | Health |
52-Week High | $33.12 | $11.78 |
52-Week Low | $19.76 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.96B | $1.36B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About StandardAero Inc. Common Stock
StandardAero, Inc. is an independent provider of aircraft engine maintenance, repair, and overhaul services, supporting commercial, military, and business aviation customers across more than 40 engine platforms.
Read more on SARO →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
